Jintanat Ananworanich Selected Research

Art Therapy

1/2022	Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection.
1/2022	Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of Infection.
10/2021	Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus.
1/2021	An Inflammatory Composite Score Predicts Mycobacterial Immune Reconstitution Inflammatory Syndrome in People with Advanced HIV: A Prospective International Cohort Study.
1/2021	Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes.
1/2021	Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features.
1/2021	Cognitive trajectories after treatment in acute HIV infection.
1/2021	Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation.
12/2020	Impact of Acute HIV Infection and Early Antiretroviral Therapy on the Human Gut Microbiome.
9/2020	A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jintanat Ananworanich Research Topics

Disease

60	HIV Infections (HIV Infection) 06/2022 - 02/2005
35	Infections 01/2022 - 08/2006
12	Viremia 10/2021 - 04/2012
11	Inflammation (Inflammations) 12/2021 - 01/2016
11	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 03/2009
7	Disease Progression 10/2022 - 05/2007
7	Neurocognitive Disorders (Clerambault Syndrome) 12/2019 - 04/2013
6	Body Weight (Weight, Body) 12/2013 - 11/2005
5	Sexually Transmitted Diseases (Sexually Transmitted Disease) 06/2011 - 09/2003
4	Coinfection 09/2020 - 01/2008
4	Cognitive Dysfunction 01/2016 - 01/2013
4	Tuberculosis (Tuberculoses) 04/2014 - 11/2009
3	Immune Reconstitution Inflammatory Syndrome 01/2021 - 11/2009
3	Hepatitis C 01/2021 - 01/2020
2	Hepatitis B 09/2020 - 05/2013
2	Atrophy 01/2020 - 07/2014
2	Chronic Renal Insufficiency 01/2018 - 09/2014
2	Encephalitis (Encephalitis, Rasmussen) 01/2018 - 01/2012
2	Fibrosis (Cirrhosis) 01/2017 - 01/2014
2	Anemia 01/2017 - 12/2012
2	Liver Diseases (Liver Disease) 01/2014 - 01/2013
2	Neoplasms (Cancer) 12/2013 - 09/2007
2	Exanthema (Rash) 11/2007 - 01/2005
1	COVID-19 01/2022
1	Syphilis 01/2021
1	Neurobehavioral Manifestations 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Dysbiosis 12/2020
1	Vaccinia 01/2020
1	Bacterial Vaginosis 11/2018
1	Persistent Infection 01/2018
1	Psychomotor Disorders 01/2018
1	HIV Seropositivity 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Acute-Phase Reaction 01/2017

Drug/Important Bio-Agent (IBA)

22	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2008
12	Biomarkers (Surrogate Marker)IBA 12/2020 - 11/2009
11	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2013
7	VaccinesIBA 01/2019 - 10/2008
5	Reverse Transcriptase InhibitorsIBA 10/2012 - 01/2005
5	NucleosidesIBA 01/2011 - 01/2005
4	AntigensIBA 01/2022 - 03/2005
3	Hemoglobins (Hemoglobin)IBA 09/2020 - 07/2013
3	N-acetyltalosaminuronic acid (NAT)IBA 09/2020 - 10/2008
3	AntibodiesIBA 12/2019 - 05/2013
3	Monoclonal AntibodiesIBA 01/2019 - 02/2016
3	EnzymesIBA 01/2019 - 10/2008
3	Tenofovir (Viread)FDA Link 01/2018 - 01/2008
3	Ritonavir (Norvir)FDA Link 10/2012 - 11/2005
2	EpitopesIBA 10/2022 - 01/2021
2	HLA Antigens (Human Leukocyte Antigens)IBA 10/2022 - 03/2013
2	Viral RNAIBA 12/2021 - 11/2021
2	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021 - 01/2020
2	Chemokine ReceptorsIBA 12/2020 - 05/2007
2	IntegrinsIBA 12/2020 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 09/2020 - 01/2017
2	Lipopolysaccharide ReceptorsIBA 09/2020 - 01/2017
2	C-Reactive ProteinIBA 09/2020 - 01/2017
2	fibrin fragment D (D-dimer)IBA 09/2020 - 01/2017
2	Emtricitabine (Emtriva)FDA Link 01/2018 - 01/2008
2	LipidsIBA 01/2017 - 03/2007
2	Vitamin D FDA LinkGeneric 01/2017 - 01/2014
2	Protons (Proton)IBA 12/2015 - 01/2012
2	Nucleic AcidsIBA 04/2015 - 10/2008
2	Raltegravir Potassium FDA Link 01/2015 - 04/2012
2	Integrase InhibitorsIBA 01/2015 - 01/2015
2	Protease Inhibitors (Protease Inhibitor)IBA 09/2014 - 03/2007
2	Nevirapine (Viramune)FDA Link 09/2014 - 01/2005
2	Pharmaceutical PreparationsIBA 01/2014 - 12/2013
2	Indinavir (Crixivan)FDA Link 10/2012 - 01/2011
2	Saquinavir (Invirase)FDA Link 01/2011 - 11/2005
1	RivaroxabanIBA 01/2022
1	Factor Xa InhibitorsIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 12/2021
1	ReaginsIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Ribosomal DNA (rDNA)IBA 12/2020
1	Histone Deacetylase InhibitorsIBA 09/2020
1	Interleukin-7 (Interleukin 7)IBA 09/2020
1	Vorinostat FDA Link 09/2020
1	P-selectin ligand proteinIBA 01/2020
1	Explosive Agents (Explosives)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	HIV AntibodiesIBA 12/2019
1	dolutegravirIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	ImmunosorbentsIBA 01/2018
1	ChemokinesIBA 01/2018
1	LipopolysaccharidesIBA 01/2017
1	Hyaluronic Acid (Hyaluronan)IBA 01/2017
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2017
1	Fatty Acid-Binding ProteinsIBA 01/2017

Therapy/Procedure

51	Therapeutics 06/2022 - 09/2003
37	Art Therapy 01/2022 - 01/2008
24	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 02/2005
9	Aftercare (After-Treatment) 01/2021 - 03/2007
2	Hormonal Contraception 01/2017 - 06/2011
2	Condoms (Condom) 08/2016 - 06/2011
1	Copper Intrauterine Devices 11/2018